Loading...
Market
Claimant Approval Rate for J&J Settlement by 2024 End
5
Resolution / Starting Odds
Less than 50% Approval • 25%
50% to 75% Approval • 25%
76% to 99% Approval • 25%
100% Approval • 25%
Official claimant vote results
Story
J&J Proposes $6.5 Billion Over 25 Years to Settle Ovarian Cancer Claims
May 1, 2024, 01:02 PM
Johnson & Johnson, through its subsidiary LLT Management LLC, has proposed a $6.5 billion settlement to resolve nearly all lawsuits in the U.S. claiming its talc-based products caused ovarian cancer. The settlement, intended to be managed through a prepackaged reorganization over 25 years, requires approval from a supermajority of claimants. This is Johnson & Johnson's third attempt to settle these disputes, involving tens of thousands of cases alleging that the company's baby powder and other talc products contain asbestos. Additionally, there are more pending lawsuits alleging that J&J products caused mesothelioma.
View original story
Similar markets
Less than 50% • 25%
50% to 74% • 25%
75% to 89% • 25%
90% or more • 25%
Less than 50% • 33%
50% to 74% • 33%
75% or more • 33%
Approved by all claimants • 25%
Approved by more than 75% but not all • 25%
Approved by more than 50% but less than 75% • 25%
Not approved by more than 50% • 25%
Significant improvement • 25%
Moderate improvement • 25%
No significant change • 25%
Worsened financial performance • 25%
Decrease more than 10% • 25%
Decrease less than 10% • 25%
Increase less than 10% • 25%
Increase more than 10% • 25%
Under 70% • 25%
70% to 80% • 25%
80% to 90% • 25%
Over 90% • 25%
Generally Positive • 33%
Neutral • 33%
Generally Negative • 34%
Below 25% approval • 25%
25%-50% approval • 25%
51%-75% approval • 25%
Above 75% approval • 25%